[Iatrogenic thyroid disorders].
Wemeau
J L
JL
Clinique endocrinologique Marc-Linquette, CHRU Lille, France.
D000638:Amiodarone / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D007370:Interferon Type I / Q000009:adverse effects; D007457:Iodine Radioisotopes / Q000009:adverse effects; D008094:Lithium / Q000009:adverse effects; D011832:Radiation Injuries / Q000209:etiology; D019275:Radiopharmaceuticals / Q000009:adverse effects; D011994:Recombinant Proteins; D013959:Thyroid Diseases / Q000139:chemically induced / Q000209:etiology*; D013961:Thyroid Gland / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D014150:Antipsychotic Agents; D000998:Antiviral Agents; D007370:Interferon Type I; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D011994:Recombinant Proteins; D008094:Lithium; D000638:Amiodarone
Thyropathies iatrogènes.